GoodRx (GDRX) free cash flow was $94M in FY2025 (-17% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$94M
-17%
2024
$114M
+38%
2023
$83M
-10%
2022
$92M
-37%
2021
$144M
+51%
2020
$96M
+23%
2019
$78M
+86%
2018
$42M
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$66M
Q1 2026
-$10M
Q4 2025
$17M
Q3 2025
$58M
Q2 2025
$31M
Q1 2025
-$12M
Q4 2024
$28M
Q3 2024
$71M
Q2 2024
-$8M
Q1 2024
$22M
Q4 2023
$3M
Q3 2023
$47M
Source: GDRX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.